Genetic epidemiology of multiple sclerosis Alastair Compston
Epidemiological studies of multiple sclerosis have been performed on almost an industrial scale over the past 90 years. Morbidity statistics have been used to generate aetiological hypotheses, to assess local needs for the provision of services and the allocation of resources, and to define the natural history of the disease. Methodological factors have limited the extent to which the many surveys have yielded definitive conclusions in any one of these contexts. Most vulnerable have been the comparisons of prevalence between regions and the serial studies of single places.
In planning an epidemiological study in multiple sclerosis, the usual practice is to retrieve cases from lists of those already known to be affected. Because in most parts of the world the diagnosis is coordinated through hospital clinics, scrutiny of departmental and office notes provides the best source of information. In some situations, a case can be made for retrospectively adjusting statistics to include those people who would have featured in a population based survey if their whereabouts or clinical status had been known at the time (onset adjusted prevalence'); their exclusion can then be regarded as an error of administration, recognition, disease expression, or any one of the quirks which makes one person seek medical advice in advance of another. Rigid application of criteria for inclusion, and the decision to omit suspected cases, will vary depending on the purposes of the study. For surveys examining biological features, the error should be towards inclusion of those who probably have the disease process even if this is not yet clinically declared. In other contexts, it is essential to restrict the register to those who definitely have the disease.
Cases of different racial origin should not be grouped because they may differ for important characteristics. Sociohistorical factors are known to create significant differences in risk status even across quite small regions; conversely, some questions relating to the epidemiology of multiple sclerosis, which involve cohort studies, can only be answered by comparing specifically different locations. It makes little sense to plan a study requiring the recruitment of significant numbers of patients with a rare manifestation of multiple sclerosis, such as twinning or familial disease, in a community which has a low overall prevalence of the disease. Similarly, a ubiquitous but biologically important feature may not differ significantly between groups in places where multiple sclerosis is relatively common. It follows that there are usually better opportunites for identifying risk factors which make a significant contribution to the disease but are frequent in the at risk population by working in areas of low prevalence; conversely, risk factors for multiple sclerosis which are not overrepresented in the normal population will be identified more easily in high prevalence regions.
The extent to which complete ascertainment is achieved depends much on the structure, size, and distribution of the denominator, and whether the population has previously been surveyed. The few patients with multiple sclerosis in a medium to low prevalence island community with a demographically stable population of around 20 000 and a normal age structure, can easily be ascertained but when surveying the disease in one at risk group living within a large metropolitan but ethnically mixed community, it may prove impossible to ascertain with confidence either the numerator or denominator, especially if recent population censuses are not available. Improved provision of facilities for the disabled inflates both prevalence and mortality; and the arrival of an investigator with a special interest in the disease abruptly increases morbidity estimates although these will plateau once ascertainment is saturated. Underestimating the absolute number of cases may not affect the definition of geographical gradients in the distribution of multiple sclerosis but it does matter in serial studies of a single region where a rise in prevalence resulting from reduced mortality and altered diagnostic criteria has to be distinguished from a real increase in incidence. It follows that investigator vigilance is a major confounding factor in comparative epidemiology.
Distribution of multiple sclerosis
By the beginning of the 20th century, multiple sclerosis-a disease that merited individual case reports 25 years previously-had become one of the commonest reasons for admission to a neurological ward. The period 1900 to 1950 saw a gradual evolution of methods pronounced differences in prevalence exist between regions and islands that are geographically close but differ in their genetic and cultural histories.9 In north America, there is a diagonal gradient in frequency with the highest rates in the midwest and the lowest in the Missisippi delta.'0 The comprehensive survey from Australia, in which four regions were surveyed simultaneously using comparable methods and working to a common prevalence date also shows a latitudinal gradient for the white Australian population with higher rates in the south than in the north."I Another classic series of epidemiological studies compared the frequency of multiple sclerosis among Japanese in Hawaii, the west coast of North America, and Japan. In Hawaii, the prevalence among Japanese was 7/105 compared with 34/105 in white immigrants to Hawaii'6S8; these rates were virtually identical for Japanese and white people living in California'9 and can be compared with the expected rate of 2/105 for native Japanese. 20 Here, the evidence favours a strong protective effect for the Japanese irrespective of environment.
The other location where migration has occurred on a sufficient scale to show important age related differences in prevalence of multiple sclerosis is Israel. The original study in immigrants reported a difference in prevalence between migrants from northern Europe (Ashkenazi Jews) and from Asia and Africa (Sephardic Jews). 21 22 The higher frequency in Ashkenazi than Sephardic Jews also showed an age at migration effect, in that there were very few Ashkenazis in the cohort arriving in Israel before adolescence. Although crude rates retained the difference seen in the parental groups, prevalence in the Israeli born children of Ashkenazi and Sephardic Jews was the same after age adjustment to the population of the United States. These important studies have recently been updated23; depending on place of paternal birth, prevalence (age adjusted to the Israeli population of 1960) was estimated at 32 (fathers born in Israel), 38 (fathers born in Europe or North America), and 29 (fathers born in Africa or Asia) compared with 14/105 in immigrants. Higher rates were found in Jerusalem (61, 68, and 51/105 for Israelis with Israeli, European/American, and African/ Asian fathers respectively) than in other parts of the country. The implication is that, at least for Ashkenazi and Sephardic Jews, racially determined differences in risk for multiple sclerosis are modified by environment.
Movements within one continent or country are also informative for the assessment of risk depending on time spent in regions of differing prevalence. A study of United States citizens showed that mortality for southern born patients dying in the north was 0-68/105/year compared with 0A46/105/year for those remaining in the south. The mortality ratio for United States army veterans born in-the high frequency northern states and entering military service from the middle zone dropped from 1-48 to 1-27, and to 0 74 for those entering from the southern states. Those born in the medium risk zone showed a ratio increase in frequency of multiple sclerosis to 1-4 if entering military service from the north and a reduced ratio of 0-73 if entering from the south. 24 All of these studies proved enormously influential in shaping ideas on the contribution of environmental factors to the aetiology of multiple sclerosis. Having established from the migration studies and analyses of epidemics that environmental factors probably do alter the risks of developing multiple sclerosis, and may override racial susceptibility, it became important to establish at what age these influences occur. Clearly, the critical period is before clinical onset and the studies from South Africa and the United States veterans' survey suggest that, in all probability, the disease process is established in childhood but few would be confident about confining risk to a particular calender age.
As part of a national survey of multiple sclerosis in France, 246 persons were identified who had migrated from north Africa in the first quinquennium of the 1960s after the Algerian war for independence, among 8000 cases ascertained overall in France.5 Excluding the 27 patients who had multiple sclerosis before, or at the time of migration, 86% of these 246 probands were European in origin and the remainder Arab or Berber. There was no apparent age or sex adjusted difference in frequency or mean age at onset between these and native French cases and this has been interpreted as indicating that the provocative exogenous factors are ubiquitous and that multiple sclerosis is acquired by the same age in each group. As far as this study is concerned, Kurtzke considers that matching by age has introduced a confounding factor as this will have restricted individual subjects to those with the same age at onset; he prefers the interpretation that in this cohort there is a fixed interval between migration and clinical onset, regardless of age, and takes the study to provide evidence for susceptibility extending to people in the mid-40s.7 However, a range of more than 30 years could be considered not to provide much insight into the critical age of exposure to the putative agent which causes multiple sclerosis.
Epidemics of multiple sclerosis Those who espouse the environmental doctrine of multiple sclerosis are naturally enthusiastic about epidemics of the disease. The arguments put forward by Kurtzke7 for point source epidemics, especially that proposed for the Faroe Islands, have not been universally accepted and others take the view that these are epidemics of recognition reflecting the arrival of specialist medical services in island communities rather than a genuine change in incidence arising from the introduction of transmissible aetiological factors into virgin populations.
In the first survey of Iceland, 168 41 patients had been ascertained of whom nine had lived abroard for three or more years and so were not considered directly to have been part of the epidemic. Kurtzke concludes that the critical factor determining the Faroes experience of multiple sclerosis was occupation by British troops between 1940 and 1945, the development of multiple sclerosis showing both a temporal and spatial relation in that villages where people lived who contributed to each of the incidence peaks were also those where troops were billeted. But some are not convinced by this analysis3637 despite robust counter claims from the main protagonists with respect to specific criticisms concerning validity of the diagnoses, exclusions, case ascertainment, definition of epidemics, and the putative role of the British occupation in the genesis of this cluster.735
In the Orkney and Shetland Islands, the incidence and prevalence of multiple sclerosis were at one time higher, almost by an order of magnitude, than in other regions. Estimates of prevalence carried out on four occasions between 1954 and 1974 showed a steady rise in frequency from Factors which predict the clinical course Apart from surveys which have assessed highly selected populations of patients, multiple sclerosis is almost always found to be more common in females than in males. The reported figures vary but a sex ratio of two females: one male is usual, irrespective of ethnicity40 41; in children, the excess of females is even more pronounced42 whereas multiple sclerosis presenting in or beyond the fifth decade more commonly affects males. 40 At diagnosis, many patients with multiple sclerosis want information on the prognosis. So-called benign multiple sclerosis is characterised by young age at onset, usually occurring in females with infrequent sensory episodes which recover fully; conversely, the prognosis is more predictably gloomy in males with older age of onset and a progressive course involving motor systems. The influence of attack rate early in the disease on outcome has been somewhat less clear. Whereas all neurologists will be familiar with patients in whom a brisk start to the disease with several nasty attacks settled down into a much more favourable middle and long term course than had at first seemed probable, the large population based studies have shown that attack rate in the early years is of some prognostic value. 40 41 43 Trauma as a trigger of disease activity in multiple sclerosis has been much considered, and still features in the law courts, where plaintiffs may claim that an accident has provoked the first appearance of multiple sclerosis or altered the course of pre-existing manifestations. Sibley et a144 prospectively studied disease activity by questionnaire and physical examination for eight years. Taking either the three or six month period after each event as at risk, only electrical trauma showed an association with new episodes; all other noted forms of trauma were negatively correlated both with clinical exacerbations and disease progression.
Siva et al,45 using the Mayo Clinic cohort, also conclude that disease exacerbations are no more frequent in the six months after limb fracture than at other times.
The situation with respect to the risk from anaesthesia is unsatisfactory in that no epidemiologically based studies have been performed and the evidence is entirely anecdotal; some neurologists advise patients to avoid elective interventions while remaining sensible about treatments or procedures which justify the small risk of increasing disease activity-if it actually exists. 46 47 Several authors have shown prospectively that new episodes of demyelination increase after (presumed) viral exposure but no single agent has been implicated48 49; 9% of presumed infections are followed by relapse and 27% of new episodes are related to infection; the relative risk for relapse in the four week period after upper respiratory (especially adenovirus) or gastrointestinal infections is 1-3.
Anecdotal evidence on whether pregnancy affects the immediate or long term course of multiple sclerosis has now been supplemented by prospective surveys which indicate that the onset of multiple sclerosis does not cluster around pregnancy, and that having children does not alter the long term course of the disease but there is an increase in relapse rate during the puerperium. However, a major confounder in the detailed interpretation of these studies is the decision by women with severe disability not to embark on pregnancy and the corresponding preparedness of those with mild disease to start or extend their families. The prospective studies indicate a roughly threefold higher risk in the three to six months after term than during pregnancy,5051 and suggest that the attacks may be more severe. 52 There is less agreement on whether or not the relapse rate is maintained or falls during the pregnancy itself, as was suggested in several of the retrospective surveys.3 In the most comprehensive epidemiological analysis of issues relating to multiple sclerosis and pregnancy, Runmarker and Andersen56 studied an inception cohort in Goteborg, Sweden and disposed of the hypothesis that the onset of multiple sclerosis is influenced by pregnancy; there was a conspicuous absence of onset bouts during pregnancy compared with non-pregnant epochs including the puerperal eight months. Fecundity was reduced in women with multiple sclerosis, presumably by choice, especially in the context of significant disability and this is the probable explanation for the conclusion that pregnancy after onset is associated with a lower risk of progression.
Familial multiple sclerosis Multiple sclerosis has a familial recurrence rate of about 15% and it is usually assumed that this is due to coinheritance of susceptibility factors, but the altemative hypothesis is that this results from common exposure to environmental factors in childhood. The most comprehensive study of recurrence (from Canada) takes as its baseline a lifetime risk of 0-2% for the entire population, and shows an increase to 3% in other first degree relatives (relative risk 20) and 1 % in second degree relatives (relative risk 5 5).57
Comparable studies from the United Kingdom confirm that the highest age adjusted recurrence rate is for sisters (4A4%) and brothers (3 2%), compared with parents (2-1%) and offspring (1 8%). Overall, the reduction in risk changes from 2-8% (relative risk 9 2) in first degree relatives to 1 -0% (relative risk 3 4) and 0 9% (relative risk 2 9) in second and third degree relatives, respectively, compared with a background age adjusted risk in this population of 0 3%.5 In Flanders, the recurrence risks are 10-fold to 1 2-fold for first degree and threefold for second degree relatives.59
With some variations in methodology, three recent studies approximate to a population based series of multiple sclerosis in twins.60 63 Two show remarkable consistency in demonstrating a higher clinical concordance rate in monozygotic twins (about 25%) than dizygotic pairs (about 3%); the French study is exceptional in showing no significant difference between monozygotic and dizygotic twins but critics have argued that this result is within the confidence limits of the other surveys. The relative risk for multiple sclerosis in the monozygotic twin partner of an affected proband is therefore about 190.
Adopted persons who subsequently develop multiple sclerosis, and affected people who have themselves adopted children provide an unusual but informative resource for studying the relative contribution of genes and the environment in the aetiology of multiple sclerosis. Considering those with multiple sclerosis who are adopted before the age of one year, and those with multiple sclerosis who through adoption have non-biological siblings or children, the frequency of multiple sclerosis in non-biological parents, siblings, and children is more or less identical to the population prevalence and lifetime risk for Europeans, and significantly lower than that expected from the study of recurrence risks in the biological relatives of index cases.64 Half siblings offer yet one more variant on the familial multiple sclerosis theme in that they share a proportion of parental genes and divide into those who are reared together and apart, at least during the period which is thought critical for the development of multiple sclerosis. The age adjusted risk for half siblings is significantly lower than for full siblings and there is no difference in risk for half siblings reared together and apart. 65 Conjugal pairs with multiple sclerosis who have children provide a special opportunity for assessing the contribution made to susceptibility by genetic factors. Five of 86 offspring from 45 ing the onset and course of multiple sclerosis. In the United Kingdom survey, there was no evidence for clinical concordance, clustering at year of onset, or distortion of the expected pattern of age at onset in the second affected spouse from 33 pairs in whom these comparisons could be made.66 Figure 5 summarises these risks.
Markers of genetic susceptibility
The change in recurrence risk seen between twins and first and second degree relatives suggests the independent or epistatic effects of more than one gene; the modest trend for affected pairs to be female hints at a contribution of sex independent of genes; the low concordance rate, even among monozygotic pairs, indicates a significant independent or modifying effect of the environment on expression of genetic susceptibility. [68] [69] [70] [71] But the contribution to susceptibility made by the genes which have provisionally been identified, even if their effects are interactive, can only account for a proportion of the increased risk of multiple sclerosis implicated by family studies; and it seems likely that other genes which make an even greater contribution to susceptibility remain to be identified.
Three groups of investigators have now undertaken a systematic search of the genome in an attempt to locate additional susceptibility genes using affected family members-usually identity by descent analysis in sibling pairs. Genotyping was completed on cohorts each of between 75 and 225 families, together involving in excess of 1000 members, for each of between 257-443 microsatellite markers. These markers were chosen to have an average spacing of around 10 cM giving enough power to identify regions encoding a major susceptibility gene; and they are sufficiently polymorphic to make a high proportion of the available families fully informative. Superficially, the results show a disappointing lack of overlap. Despite inconsistencies between the samples, it remains possible that meta-analysis will provide stronger evidence implicating one or more of these provisional areas of linkage, and the hope is that many of the false positive leads will be eliminated while larger clinical resources are deployed and new strategies pursued for detecting both linkage and new associations within families.
Analysing the epidemiological pattern in multiple sclerosis
The complex interplay of nature and nurture is reflected in the distribution of many diseases; some, such as malaria and the haemoglobinopathies, are reasonably well understood, but factors which determine the geography of complex traits remain much more enigmatic. 
